By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellectis and Genoway said that they have reached an agreement on how to handle orders of products covered by a licensing agreement between the firms that was terminated in late 2008.

In December 2008, Cellectis terminated a non-exclusive license that granted Genoway access to patents covering certain uses of homologous recombination. The initial license had been signed in 2001.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.